CPRX - Catalyst Pharmaceuticals, Inc. Stock Price and Quote

CPRX [NASD]

Index	-	P/E	22.09	EPS (ttm)	0.74	Insider Own	5.90%	Shs Outstand	104.60M	Perf Week	3.29%
Market Cap	1.73B	Forward P/E	8.82	EPS next Y	1.87	Insider Trans	-17.96%	Shs Float	97.66M	Perf Month	8.82%
Income	83.10M	PEG	-	EPS next Q	0.32	Inst Own	83.20%	Short Float / Ratio	10.02% / 4.22	Perf Quarter	-9.22%
Sales	214.20M	P/S	8.07	EPS this Y	103.70%	Inst Trans	10.30%	Short Interest	9.78M	Perf Half Y	31.10%
Book/sh	2.87	P/B	5.74	EPS next Y	23.64%	ROA	27.20%	Target Price	21.65	Perf Year	101.09%
Cash/sh	2.84	P/C	5.79	EPS next 5Y	-	ROE	32.20%	52W Range	6.15 - 22.11	Perf YTD	-10.48%
Dividend	-	P/FCF	-	EPS past 5Y	40.50%	ROI	26.70%	52W High	-24.70%	Beta	1.10
Dividend %	-	Quick Ratio	5.50	Sales past 5Y	-	Gross Margin	83.90%	52W Low	170.73%	ATR	0.65
Employees	82	Current Ratio	5.60	Sales Q/Q	58.70%	Oper. Margin	47.50%	RSI (14)	59.13	Volatility	3.45% 4.44%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	160.00%	Profit Margin	38.80%	Rel Volume	0.41	Prev Close	16.46
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 15 AMC	Payout	0.00%	Avg Volume	2.32M	Price	16.65
Recom	2.20	SMA20	6.22%	SMA50	5.37%	SMA200	18.30%	Volume	299,468	Change	1.15%

Aug-24-22

Downgrade

ROTH Capital

Buy → Neutral

$10 → $15.50

Sep-21-18

Initiated

Cantor Fitzgerald

Overweight

Sep-07-18

Resumed

Piper Jaffray

Overweight

Oct-05-16

Upgrade

Piper Jaffray

Neutral → Overweight

Apr-26-16

Downgrade

Piper Jaffray

Overweight → Neutral

$6 → $1

Sep-30-14

Reiterated

ROTH Capital

Buy

$5 → $6

Sep-16-14

Reiterated

ROTH Capital

Buy

$3.50 → $5

Sep-15-14

Reiterated

H.C. Wainwright

Buy

$5 → $13

Oct-21-13

Reiterated

Aegis Capital

Buy

$4 → $5.50

Sep-24-13

Initiated

Maxim Group

Buy

Show Previous Ratings

Mar-27-23 05:50PM	Catalyst Pharmaceutical (CPRX) Outpaces Stock Market Gains: What You Should Know Zacks
07:12AM	Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 574% Simply Wall St.
Mar-22-23 09:55AM	Wall Street Analysts Think Catalyst (CPRX) Could Surge 26.44%: Read This Before Placing a Bet Zacks
Mar-21-23 05:50PM	Catalyst Pharmaceutical (CPRX) Gains But Lags Market: What You Should Know Zacks
09:00AM	Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now? Zacks
09:30AM	Loading…
Mar-17-23 09:30AM	Is It Worth Investing in Catalyst (CPRX) Based on Wall Street's Bullish Views? Zacks
Mar-16-23 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Catalyst (CPRX) Zacks +9.83%
Mar-15-23 05:25PM	Catalyst Pharmaceutical (CPRX) Q4 Earnings and Revenues Surpass Estimates Zacks
04:11PM	Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update GlobeNewswire
Mar-13-23 06:30AM	7 Core Stocks to Build a Solid Portfolio Around InvestorPlace
Mar-10-23 09:00AM	Catalyst Pharmaceuticals, Inc. (CPRX) is Attracting Investor Attention: Here is What You Should Know Zacks
Mar-09-23 10:00AM	MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Mar-08-23 11:20AM	Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies GlobeNewswire
10:00AM	Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Mar-01-23 08:03AM	Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on March 15, 2023 GlobeNewswire
06:30AM	Loading…
Feb-28-23 06:30AM	7 Smart Stock Picks for Cautious Investors InvestorPlace
Feb-27-23 05:50PM	Catalyst Pharmaceutical (CPRX) Outpaces Stock Market Gains: What You Should Know Zacks
12:10PM	Will Catalyst (CPRX) Beat Estimates Again in Its Next Earnings Report? Zacks
09:00AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises Zacks
09:00AM	Catalyst Pharmaceuticals, Inc. (CPRX) Is a Trending Stock: Facts to Know Before Betting on It Zacks
Feb-24-23 12:45PM	Is Catalyst (CPRX) a Solid Growth Stock? 3 Reasons to Think "Yes" Zacks
Feb-22-23 08:03AM	Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day GlobeNewswire
Feb-21-23 05:50PM	Catalyst Pharmaceutical (CPRX) Stock Moves -1.74%: What You Should Know Zacks
Feb-15-23 09:30AM	Is Catalyst (CPRX) a Buy as Wall Street Analysts Look Optimistic? Zacks
09:00AM	Investors Heavily Search Catalyst Pharmaceuticals, Inc. (CPRX): Here is What You Need to Know Zacks
Feb-13-23 05:50PM	Catalyst Pharmaceutical (CPRX) Gains But Lags Market: What You Should Know Zacks
07:36AM	Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? Simply Wall St.
Feb-08-23 12:45PM	Catalyst (CPRX) is an Incredible Growth Stock: 3 Reasons Why Zacks -5.61%
Feb-07-23 08:03AM	Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance GlobeNewswire
Feb-06-23 05:50PM	Catalyst Pharmaceutical (CPRX) Dips More Than Broader Markets: What You Should Know Zacks
05:14PM	Loading…
05:14PM	The 7 Best Growth Stocks to Buy for February 2023 InvestorPlace
Feb-03-23 09:00AM	Here is What to Know Beyond Why Catalyst Pharmaceuticals, Inc. (CPRX) is a Trending Stock Zacks
Jan-30-23 05:50PM	Catalyst Pharmaceutical (CPRX) Gains As Market Dips: What You Should Know Zacks
Jan-26-23 09:22AM	Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed? Motley Fool
Jan-25-23 08:03AM	Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII GlobeNewswire
02:54AM	Strength Seen in Catalyst (CPRX): Can Its 9.2% Jump Turn into More Strength? Zacks
Jan-23-23 01:25PM	Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra GlobeNewswire -29.04%
12:45PM	3 Reasons Growth Investors Will Love Catalyst (CPRX) Zacks
09:00AM	Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now? Zacks
08:30AM	Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today Zacks
08:03AM	Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE® GlobeNewswire
Jan-19-23 06:00PM	Catalyst Pharmaceutical (CPRX) Dips More Than Broader Markets: What You Should Know Zacks
Jan-10-23 09:00AM	Is Most-Watched Stock Catalyst Pharmaceuticals, Inc. (CPRX) Worth Betting on Now? Zacks
Jan-05-23 08:30AM	Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago Zacks
Dec-28-22 11:58PM	12 Best Performing NASDAQ Stocks in 2022 Insider Monkey
10:15PM	12 Best Performing Biotech Stocks in 2022 Insider Monkey
Dec-20-22 08:30AM	If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now Zacks +13.35%
Dec-19-22 04:10PM	Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd GlobeNewswire
Dec-16-22 04:30PM	This Growth Stock's Jaw-Dropping Run-Up Is Smashing Tesla's Motley Fool
08:09AM	Are Investors Undervaluing Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) By 50%? Simply Wall St.
Dec-14-22 09:00AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises Zacks
Dec-13-22 09:35AM	Catalyst Pharmaceutical (CPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors Zacks
Dec-12-22 03:44PM	12 Best Small-Cap Healthcare Stocks To Buy Now Insider Monkey +6.29%
Dec-09-22 11:30AM	Catalyst (CPRX) Up 8.9% Since Last Earnings Report: Can It Continue? Zacks
Dec-02-22 08:30AM	If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now Zacks
Nov-28-22 10:23AM	10 Robinhood Stocks To Buy That Are Too Cheap To Ignore Insider Monkey
Nov-14-22 12:45PM	Here is Why Growth Investors Should Buy Catalyst (CPRX) Now Zacks +7.51%
09:40AM	Are Medical Stocks Lagging Catalyst Pharmaceuticals (CPRX) This Year? Zacks
08:30AM	Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today Zacks
Nov-11-22 09:49AM	Here's Why Catalyst Pharmaceuticals (NASDAQ:CPRX) Has Caught The Eye Of Investors Simply Wall St. -5.06%
Nov-09-22 05:35PM	Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates Zacks -5.35%
04:11PM	Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update GlobeNewswire
Nov-07-22 08:03AM	Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year GlobeNewswire +7.04%
Nov-04-22 04:46AM	Strength Seen in Alpine Immune Sciences, Inc. (ALPN): Can Its 7.5% Jump Turn into More Strength? Zacks
Oct-25-22 08:03AM	Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022 GlobeNewswire
Oct-21-22 09:30AM	These 3 Stocks Are Winning the Bear Market -- Here's How Motley Fool +5.05%
Oct-19-22 09:40AM	Are Medical Stocks Lagging Catalyst Pharmaceuticals (CPRX) This Year? Zacks
Oct-18-22 07:02AM	The 6.3% return this week takes Catalyst Pharmaceuticals' (NASDAQ:CPRX) shareholders five-year gains to 375% Simply Wall St.
Oct-03-22 09:40AM	Is Catalyst Pharmaceuticals (CPRX) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-29-22 11:18AM	Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients GlobeNewswire
Sep-28-22 10:30AM	2 No-Brainer Stocks to Buy Right Now for Less Than $15 Motley Fool
Sep-15-22 12:45PM	Looking for a Growth Stock? 3 Reasons Why Catalyst (CPRX) is a Solid Choice Zacks -12.24%
12:00PM	Catalyst (CPRX) Upgraded to Buy: Here's What You Should Know Zacks
09:40AM	Is Catalyst Pharmaceuticals (CPRX) Outperforming Other Medical Stocks This Year? Zacks
Sep-13-22 05:53PM	As Markets Plunged, These 2 Stocks Hit All-Time Highs Motley Fool
Sep-12-22 07:30PM	Catalyst Pharmaceuticals Set to Join S&P SmallCap 600 PR Newswire
08:30AM	Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago Zacks
Sep-09-22 08:45AM	Why Catalyst Pharmaceuticals Stock Marched Higher This Week Motley Fool
08:03AM	Catalyst Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference GlobeNewswire
Sep-08-22 11:30AM	Catalyst (CPRX) Up 13.3% Since Last Earnings Report: Can It Continue? Zacks
09:35AM	Catalyst Pharmaceutical (CPRX) Just Reclaimed the 20-Day Moving Average Zacks
Sep-05-22 01:46PM	Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St.
Aug-26-22 12:45PM	3 Reasons Why Catalyst (CPRX) Is a Great Growth Stock Zacks
12:00PM	Here's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy Zacks
09:40AM	Has Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year? Zacks
08:30AM	If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now Zacks
Aug-24-22 08:03AM	Catalyst Pharmaceuticals To Participate in Citi's 17th Annual BioPharma Conference GlobeNewswire -6.30%
Aug-23-22 10:53AM	Got $2,500? These 2 Small-Cap Monsters Are Crushing Tesla Stock Motley Fool
Aug-09-22 06:35PM	Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates Zacks
04:25PM	Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update GlobeNewswire
Jul-26-22 08:03AM	Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022 GlobeNewswire
Jul-14-22 06:01AM	Catalyst (CPRX) Stock Jumps 10%: Will It Continue to Soar? Zacks
Jul-12-22 06:00AM	Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical GlobeNewswire
Jun-25-22 08:15AM	What Type Of Shareholders Own The Most Number of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares? Simply Wall St.
Jun-09-22 11:30AM	Catalyst (CPRX) Up 6.9% Since Last Earnings Report: Can It Continue? Zacks
Jun-04-22 11:07AM	Is Now the Time to Buy This Risky Stock With Huge Upside Potential? Motley Fool
May-17-22 08:03AM	Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
May-11-22 06:05AM	Catalyst Pharmaceuticals (NASDAQ:CPRX) pulls back 10% this week, but still delivers shareholders solid 27% CAGR over 5 years Simply Wall St. -6.06%
May-10-22 05:25PM	Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings and Revenue Estimates Zacks +5.96%
04:11PM	Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update GlobeNewswire

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Del Carmen Jeffrey	Chief Commercial Officer	Mar 29	Option Exercise	3.18	40,000	127,063	28,524	Mar 30 05:01 PM
GRANDE ALICIA	VP, Treasurer and CFO	Mar 29	Option Exercise	1.13	50,000	56,500	100,557	Mar 30 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Mar 29	Sale	16.70	50,000	835,100	50,557	Mar 30 05:00 PM
Del Carmen Jeffrey	Chief Commercial Officer	Mar 29	Sale	16.70	40,000	667,810	7,541	Mar 30 05:01 PM
GRANDE ALICIA	VP, Treasurer and CFO	Mar 28	Option Exercise	0.79	58,216	45,991	108,773	Mar 30 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Mar 28	Sale	16.54	58,216	962,786	50,557	Mar 30 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Mar 22	Option Exercise	0.79	41,784	33,009	89,081	Mar 24 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Mar 22	Sale	16.50	41,784	689,528	50,557	Mar 24 05:00 PM
Elsbernd Brian	Chief Compliance/Legal Officer	Mar 20	Option Exercise	1.13	50,000	56,500	188,076	Mar 22 04:45 PM
Elsbernd Brian	Chief Compliance/Legal Officer	Mar 20	Sale	16.07	50,000	803,450	138,076	Mar 22 04:45 PM
DENKHAUS DONALD A	Director	Jan 24	Option Exercise	0.79	50,000	39,500	329,000	Jan 27 04:30 PM
O'Keeffe Charles B	Director	Jan 24	Option Exercise	0.79	50,000	39,500	616,391	Jan 27 04:30 PM
INGENITO GARY	Chief Medical Officer	Dec 06	Sale	16.85	5,918	99,718	30,802	Dec 08 05:03 PM
Miller Steve	Chief Operating Officer	Nov 23	Sale	17.34	20,000	346,740	553,791	Nov 23 05:01 PM
COELHO PHILIP H	Director	Nov 23	Sale	17.45	9,999	174,483	149,553	Nov 23 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Nov 22	Sale	16.53	120,000	1,983,240	27,442	Nov 23 05:02 PM
COELHO PHILIP H	Director	Nov 22	Sale	17.30	20,001	346,097	159,552	Nov 23 05:00 PM
MCENANY PATRICK J	President and CEO	Nov 21	Option Exercise	2.24	150,000	336,000	4,052,606	Nov 22 05:00 PM
MCENANY PATRICK J	President and CEO	Nov 21	Sale	15.33	150,000	2,299,800	3,902,606	Nov 22 05:00 PM
Miller Steve	Chief Operating Officer	Nov 21	Sale	15.28	80,000	1,222,080	573,791	Nov 23 05:01 PM
COELHO PHILIP H	Director	Nov 21	Sale	15.23	70,000	1,066,170	179,553	Nov 23 05:00 PM
MCENANY PATRICK J	President and CEO	Nov 18	Option Exercise	2.24	350,000	784,000	4,252,606	Nov 22 05:00 PM
MCENANY PATRICK J	President and CEO	Nov 18	Sale	15.62	350,000	5,467,700	3,902,606	Nov 22 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Nov 15	Sale	15.77	60,000	946,080	147,442	Nov 17 05:00 PM
Elsbernd Brian	Chief Compliance/Legal Officer	Nov 14	Option Exercise	1.45	105,000	151,850	116,096	Nov 15 05:00 PM
Del Carmen Jeffrey	Chief Commercial Officer	Nov 11	Option Exercise	2.78	139,017	385,798	120,000	Nov 15 05:00 PM
Sundaram Preethi	Chief Strategy Officer	Nov 11	Option Exercise	5.49	56,786	311,755	56,786	Nov 15 05:01 PM
Del Carmen Jeffrey	Chief Commercial Officer	Nov 11	Sale	16.12	139,017	2,241,382	0	Nov 15 05:00 PM
Sundaram Preethi	Chief Strategy Officer	Nov 11	Sale	16.38	56,786	929,871	0	Nov 15 05:01 PM
DENKHAUS DONALD A	Director	Nov 11	Sale	16.59	20,000	331,880	277,666	Nov 15 05:00 PM
Elsbernd Brian	Chief Compliance/Legal Officer	Nov 11	Sale	16.23	14,666	238,103	11,096	Nov 15 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Sep 23	Sale	11.90	60,000	713,940	207,442	Sep 26 05:01 PM
GRANDE ALICIA	VP, Treasurer and CFO	Sep 16	Sale	13.50	90,000	1,214,640	267,442	Sep 20 05:00 PM
Sundaram Preethi	Chief Strategy Officer	Sep 15	Option Exercise	5.49	18,214	99,995	18,214	Sep 16 05:01 PM
Sundaram Preethi	Chief Strategy Officer	Sep 15	Sale	14.49	18,214	263,921	0	Sep 16 05:01 PM
INGENITO GARY	Chief Medical & Reg. Officer	Sep 14	Option Exercise	4.40	143,000	628,870	110,053	Sep 16 05:00 PM
MCENANY PATRICK J	President and CEO	Sep 14	Sale	15.41	946,846	14,594,684	3,902,606	Sep 15 05:01 PM
INGENITO GARY	Chief Medical & Reg. Officer	Sep 14	Sale	15.67	143,000	2,241,459	22,053	Sep 16 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Sep 14	Sale	15.57	50,000	778,650	357,442	Sep 16 05:00 PM
COELHO PHILIP H	Director	Sep 14	Sale	15.75	20,000	315,000	249,553	Sep 15 05:00 PM
DENKHAUS DONALD A	Director	Sep 14	Sale	15.34	20,000	306,800	297,666	Sep 15 05:02 PM
Miller Steve	Chief Operating Officer	Sep 13	Sale	16.90	107,933	1,824,367	653,791	Sep 15 05:01 PM
MCENANY PATRICK J	President and CEO	Sep 13	Sale	15.33	80,765	1,238,047	4,849,452	Sep 15 05:01 PM
COELHO PHILIP H	Director	Sep 13	Sale	15.70	10,000	157,000	269,553	Sep 15 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 29	Sale	14.20	57,000	809,560	407,442	Aug 30 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 26	Sale	14.40	11,095	159,768	464,442	Aug 30 05:00 PM
Daly Richard J	Director	Aug 24	Option Exercise	2.53	40,000	101,200	92,666	Aug 26 05:01 PM
Tierney David S	Director	Aug 22	Option Exercise	2.53	20,000	50,600	328,207	Aug 23 05:01 PM
Tierney David S	Director	Aug 22	Sale	14.16	20,000	283,180	308,207	Aug 23 05:01 PM
MCENANY PATRICK J	President and CEO	Aug 19	Option Exercise	2.53	125,000	316,250	5,055,217	Aug 19 05:02 PM
MCENANY PATRICK J	President and CEO	Aug 19	Sale	14.10	125,000	1,762,425	4,930,217	Aug 19 05:02 PM
MCENANY PATRICK J	President and CEO	Aug 18	Option Exercise	2.53	175,000	442,750	4,980,217	Aug 19 05:02 PM
Miller Steve	Chief Operating Officer	Aug 18	Option Exercise	2.53	150,000	379,500	880,299	Aug 19 05:03 PM
O'Keeffe Charles B	Director	Aug 18	Option Exercise	2.53	40,000	101,200	653,042	Aug 19 05:03 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 18	Option Exercise	2.53	19,259	48,725	494,796	Aug 19 05:02 PM
MCENANY PATRICK J	President and CEO	Aug 18	Sale	13.94	175,000	2,440,350	4,930,217	Aug 19 05:02 PM
Miller Steve	Chief Operating Officer	Aug 18	Sale	13.53	150,000	2,029,922	761,724	Aug 19 05:03 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 18	Sale	13.70	19,259	263,848	475,537	Aug 19 05:02 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 17	Option Exercise	2.53	130,741	330,775	574,853	Aug 19 05:02 PM
COELHO PHILIP H	Director	Aug 17	Option Exercise	2.53	40,000	101,200	279,553	Aug 19 05:02 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 17	Sale	13.86	130,741	1,811,635	475,537	Aug 19 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 22	Option Exercise	4.13	6,152	25,408	28,205	Jun 23 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 22	Sale	6.61	6,152	40,646	22,053	Jun 23 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 21	Option Exercise	4.13	143,848	594,092	165,901	Jun 23 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 21	Sale	6.59	143,848	948,678	22,053	Jun 23 05:02 PM
Tierney David S	Director	May 20	Option Exercise	2.53	20,000	50,600	328,207	May 24 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience